Citations

Clear

3032 citation(s) found for "Ma, Kevin".

Reframing the Spectrum of Benign Prostatic Hyperplasia Management: Impact and Implications of the 2026 AUA Guideline
Wymer, Kevin M., Koo, Kevin , Wymer, Kevin

Mayo Clinic

Journal of Urology | June 12, 2026 | Volume: 216 | Issue: 4 | Pages: 494-496

10.1097/ju.0000000000005162 | PMID 42284178 Get It

Cerebral Small Vessel Disease as an Independent Predictor of Functional Outcomes Following Traumatic Brain Injury (P4-4.022)
Safa, Adrian , Salomon, Gary, Barrett, Kevin, Salomon, Gary R.

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215771 Get It

Society Communications: Practice Tools for VTE Care and Highlights from the 2026 Fellows/APP Course
Ahsan, Syed , Cohoon, Kevin P. , Echevarria, Carlos, Henkin, Stanislav , Sondh, Sahibaan, Thomas, Sneha, Vlazny, Danielle T. , Yadav-Malhorta, Aditi, Cohoon, Kevin , Vlazny, Danielle , Henkin, Stanislav , Ahsan, Syed, Echevarria, Carlos R.

Mayo Clinic

Vascular Medicine | June 10, 2026 | Volume: 31 | Issue: 3 | Pages: 453-459

10.1177/1358863x261448517 | PMID 42267769 Get It

Continuous integral debridement: optimising wound bed preparation through the cleanse, debride, cleanse and dress cycle
Dowsett, Caroline, Gonçalves, Viviana , Melin, M Mark, Moodley, Prashini , Stuermer, Ewa Klara , Maella, Natalia, Howaldt, Monira Nou, Probst, Sebastian, Woo, Kevin, Mayer, Dieter , Atkin, Leanne , Dowsett, Caroline , Kalan, Lindsay , Pastar, Irena , Melin, M. Mark , Stuermer, Ewa K. , Maella-Rius, Natalia , Nou, Monira , Probst, Sebastian

Mayo Clinic

Journal of Wound Care | June 10, 2026 | Volume: 35 | Issue: Sup6d | Pages: No page available

10.12968/jowc.2026.0275 | PMID 42267756 Get It

In 2024, the Journal of Wound Care ( JWC ) published best-practice guidance on wound debridement. This introduced the concept of integral debridement, defined as the combined use of complementary debridement methods on the same wound to optimise healing outcomes. This typically involves combining less invasive approaches, such as autolytic debridement, with more active adjunctive methods, including mechanical and/or sharp debridement. In 2026, JWC convened an expert panel to explore how this concept can be effectively implemented in non-specialist settings. The panel concluded that debridement is most effective when applied repeatedly throughout the healing process and introduced the concept of continuous integral debridement (CID), a cyclical four-step approach comprising cleanse, debride, cleanse and dress (CDCD). The panel propose that, when performed regularly, this will help disrupt microbial and non-microbial barriers to healing and maintain a clean wound environment. The panel consider that CID is compatible with established frameworks, such as TIME/TIMERS and the International Wound Infection Institute wound infection continuum, and complements antibiofilm strategies, including Wound Hygiene. This document provides practical guidance for integrating CID into routine wound care across all clinical settings, including recommendations on cleansing solutions, debridement methods and dressing selection, with the aim of supporting evidence-based practice and improving patient outcomes.
The Reality of Benign Prostatic Hyperplasia Surgery Price and Reimbursement Across Top United States Hospitals
Murray, Gillian, Edmonds, Victoria, Borah, Bijan, Kelleher, Dan , Wymer, Kevin , Edmonds, Victoria S. , Borah, Bijan J.

Mayo Clinic

Urology Practice | June 9, 2026 | Volume: 13 | Issue: 5 | Pages: 495-502

10.1097/upj.0000000000001033 | PMID 42262115 Get It

Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activity
Liseth, Olivia , Appleton, Elizabeth, Kendall, Benjamin, Thompson, Jill , Sangsuwannukul, Thanich , Tonne, Jason , Díaz, Rosa María, Evgin, Laura , Patrikeev, Anton , Sarbia, Nicolás , Foo, Shane , Harrington, K., Ono, Masahiro , Melcher, Alan , Vile, Richard G. , Harrington, Kevin J. , Kendall, Benjamin L. , Kendall, Benjamin Luke , Harrington, Kevin , Vile, Richard G , Melcher, Alan A , Liseth, Olivia Y , Ono, Masahiro

Mayo Clinic

Science Advances | June 5, 2026 | Volume: 12 | Issue: 23 | Pages: No page available

10.1126/sciadv.aef5331 | PMID 42247513 Get It

Chimeric antigen receptor (CAR) T cell therapy faces many challenges against solid tumors including T cell exhaustion and poor CAR durability. Here, we show that engaging the CAR T cell endogenous T cell receptor (TCR) using an oncolytic virus enhances CAR T cell functionality, durability, and therapy. Upon combination therapy of solid tumors with CAR T cells and vesicular stomatitis virus (VSV), a subpopulation of antiviral, TCR-primed CAR T cells was generated with enhanced effector functions, altered activation states, and differential gene and protein expression when compared to non–TCR-primed CAR T cells. Single-cell RNA sequencing showed clonal expansion of anti-VSV CAR T cells and enhancement of effector-associated genes with VSV-mediated CAR T cell expansion. CD4 T cells played a pivotal role in the development of these TCR-primed CAR T cells. These results provide a strong rationale both for a novel use of systemic oncolytic virotherapy and for directly exploiting the CAR T cell TCR to fine tune the CAR T cell phenotype and function.
Genomic Entropy confers an aggressive Phenotype in Mesothelioma
Oketch, John, Poile, Charlotte , Dungey, Maurice , Kuse, Nathaniel, Rogel, Jan, Moazzen, Hesam, Ibrahim, Tasneem, Kutywayo, Kudzayi , Sabil, Ihsaan, Ramalamgam, Shreya, Nusrat, Nada, Lin, Yue, Buckler, Daniel, Alhazmi, Mazin, Dawson, Alan, Kwong, Francois, Barmpoutis, Panagiotis , Bajaj, Amrita, Hopewell, Heath, Sharkey, Annabel, Busacca, Sara , Richards, C, Wells-Jordan, Peter, Groot-Lipman, Kevin, Hahne, Jens , Yang, Haining, Carbone, Michele, Mansfield, A., Hollox, Edward, Zhang, Min , Luo, Jinli, Fennell, Dean Anthony , Oketch, John W. , Dungey, Maurice R. , Kuse, Nathaniel Chiwam, Działo, Joanna , Nakas, Apostolos , Sabil, I., Bzura, Aleksandra , Buckler, Daniel, Alhazmi, Mazin H. W. , Dawson, Alan, Yang, Hongji , Badge, Richard M. , Tufarelli, Cristina , Bajaj, Amrita , Lipman, Kevin B. W. Groot , Hahne, Jens, Mansfield, Aaron S. , Hollox, Edward J. , Zhou, Huiyu

Mayo Clinic

No container title available | June 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-8874509/v1 Get It

Abstract Exposure to asbestos is the primary cause of mesothelioma, however the processes underpinning its initiation and evolutionary trajectory remain elusive. To address this knowledge gap, we conducted whole exome sequencing and phylogenetic analysis of 277 mesotheliomas. Using multidimensional Dirichlet process clustering we inferred phylogenies, uncovering mutation order dominated by early 13q,1p, 8p, 6q and 22q somatic copy number alterations. Mesotheliomas exhibit a spectrum of genomic intra-tumor heterogeneity spanning linear (L) to highly branched (B) tree topologies, quantifiable by the Weighted Shannon Entropy (WSE). Somatic copy number alterations emerge earlier than single nucleotide variants (SNVs), and at a much faster relative rate in L-mesotheliomas. BAP1 is the only positively selected driver in L-mesotheliomas, whereas, B-mesotheliomas harbor multiple positively selected drivers and an aggressive phenotype, including a bias of loss of RPL5, and MTAP deletion linked to breakpoint enriched with long interspersed nuclear elements. L-trees had lower WSE, but greater T-cell inflammation and tertiary lymphoid structures, despite having a lower neoantigen burden. WSE is higher in larger volume, immunologically cold mesotheliomas, and is associated with shorter survival. In summary, progressive genomic heterogeneity is a defining feature of more aggressive mesothelioma yet illuminates opportunities for precision therapeutic intervention.